Start Investing in StocksTraders beat market returns with our 4X Leverage on Equity Delivery.
Home/ Stocks/ AARTIDRUGS

AARTI DRUGS LTD. Share Price | Rupeezy

₹479 -9.00-1.84 %(in 1 day)

AARTIDRUGS Fundamentals

Dividend Yield
P/E Ratio
P/B Ratio
Debt to Equity


577.54 CrSep'23 (Standalone)
All values in Rs. Cr
Shareholding Pattern
About Company

Aarti Drugs Limited (ADL) is a prominent manufacturer of APIs, Pharma Intermediates, and Specialty Chemicals. The Company operates as part of the Aarti Group, a conglomerate with a net worth of USD 900 million. With over 50 compounds for Antibiotics, Anti Protozoal, Anti-Inflammatory, Anti-diabetic, Anti Fungal and Cardioprotectant therapeutic segments, the Company has emerged as market leader in APIs. It has a wholly-owned subsidiary called Pinnacle Life Science Private Limited which operates in the field of manufacturing formulations. The Company has two R&D divisions, one in Tarapur and the other in Turbhe, Maharashtra. It has 3 subsidiaries, namely, Pinnacle Life Science Private Limited, Aarti Speciality Chemicals Limited and Pinnacle Chile SpA (foreign subsidiary). Of the above subsidiaries, Pinnacle Life Science Private Limited and Aarti Speciality Chemicals Limited are wholly owned subsidiaries.The manufacturing units of the Company are GMP certified. Their products include Active Pharmaceutical Ingredients (APIs), Steroids, Pharmaceutical Intermediates, and Specialty Chemicals, such as Benzene Sulphonyl Chloride, Benzene Sulphonic Acid/ Ammonium/ Sodium Salt and Benzene Sulphonamide. Aarti Drugs Ltd, a part of Aarti Group of Industries, was incorporated in September 28th, 1984. In the year 1993, the company implemented the second phase of their backward integration project and set up facilities for glyoxal (the main raw material for imidazoles). During the year 1994-95, the company commissioned a plant to recover and market ammonium sulphate derived from plant effluents. Also, Rupal Chemical Industries, a group company, was amalgamated with the company.During the year 1996-97, the company started their production of secnidazole and dichlofenac sodium. During the year 2000-01, they started the commercial production of Pharmaceutical Ingredients. During the year 2002-03, the company expanded the production capacity of bulk drugs by 598,000 kg to 17,430,000 kg. During the year 2003-04, the company further expanded the production capacity of bulk drugs by 588,000 kg to 18,018,000 kg. During the year 2004-05, the company started commercial production at their newly setup intermediate plant at Tarapur. During the year 2005-06, the company increased the production capacity of Pharmaceutical by 2,325,000 kg to 24,020,000 kg. They entered into joint venture with Chinese company engaged in Active Pharmaceutical Ingredients (APIs) manufacturing and formed Huanggang Yinhe Aarti Pharmaceutical Company Ltd for manufacturing and selling of APIs in China. Also, they acquired controlling stake in Suyash Laboratories Ltd so as to make the said company a subsidiary of the company.During the year 2006-07, the company increased the production capacity by 570,000 kg to 24,590,000 kg. During the next year, they increased the production capacity by 399,000 kg to 24,989,000 kg. During the year 2008-09, they further increased the production capacity of Pharmaceutical by 50,000 kg to 25,000,000 kg.During the year 2009-10, the company carried out research and development work/ process improvement work in bulk drugs, such as antihistaminic/anti-allergic, anti-inflammatory and anti-diabetic. ADL has exported intermediates, such as Stage-I of pioglitazone and AU-% for tamsulosin and have expanded the production capacity from 25,000,000 kg to 25,716,000 kg. A Scheme of Amalgamation of Suyash Laboratories Ltd., wholly owned subsidiary of the Company, with the Company became operative w.e.f. from 1st April, 2011, being the Appointed Date upon filing of High Court Order sanctioning the said Scheme with the Registrar of Companies on 6th July, 2012.During year 2015, Company acquired 100% equity shares in Pinnacle Life Science Pvt. Ltd., situated at Baddi, Himachal Pradesh. During the year 2020, Company incorporated 2 overseas Subsidiaries and 1 Domestic subsidiary Company. Pinnacle Chile SpA, incorporated in Santiago, Chile, was established for marketing the formulation of drugs and participating in the tender and private market in Chile. Aarti Speciality Chemicals Limited (Wholly Owned Subsidiary), located in Mumbai, was founded for carrying on the business of manufacturers, producers, processors, buyers, sellers, importers, exporters and/ or otherwise dealers in Speciality and other chemicals, pharmaceuticals and drugs. During the year 2021, Pinnacle Life Science LLC, Wholly Owned Subsidiary was wound up/ closed as said Company did not have any business activity.In 2022, the Company commissioned brownfield expansion of Speciality Chemical Plant at Tarapur, which turned operational effective from May 2022.
Show More

Ans: Share price of AARTI DRUGS LTD. is 479 today.

Ans: AARTI DRUGS LTD. opened at 489 today.

Ans: AARTI DRUGS LTD. closed at 488 previous trading day

Ans: Today's High price of AARTI DRUGS LTD. is : 575 and Today's Low price of AARTI DRUGS LTD. is : 383

Ans: 52 weeks High price of AARTI DRUGS LTD. is : 646

Ans: 52 weeks High price of AARTI DRUGS LTD. is : 314

Ans: P/E ratio of AARTI DRUGS LTD. is : 20.47

Ans: P/B ratio of AARTI DRUGS LTD. is : 2.81

Ans: You can buy/sell AARTI DRUGS LTD. through Rupeezy App or Rupeezy Web